# A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' Heart

> **NCT03665194** · PHASE1 · COMPLETED · sponsor: **Cassiopea SpA** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Cortexolone 17α-propionate solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03665194
- **Lead sponsor:** Cassiopea SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-06
- **Primary completion:** 2018-09-12
- **Final completion:** 2018-09-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665194, "A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' Heart". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03665194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*